Clinical overview of hypertension and emerging treatment considerations

American Journal of Hypertension

Volumn 14, Issue 7 II, 2001, Pages

  Cushman, William C ^a  

^a UNIVERSITY OF TENNESSEE COLLEGE OF MEDICINE   (United States)

Author keywords

Diastolic blood pressure; Hypertension; Measures; Pulse pressure; Systolic blood pressure

Indexed keywords

AMILORIDE; ATENOLOL; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CAPTOPRIL; CHLORTALIDONE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; NITRENDIPINE;

ANTIHYPERTENSIVE THERAPY; CONFERENCE PAPER; DIABETES MELLITUS; DIASTOLIC BLOOD PRESSURE; DISEASE ASSOCIATION; DRUG SAFETY; DRUG TOLERABILITY; HEALTH HAZARD; HUMAN; HYPERTENSION; MORBIDITY; MORTALITY; PRIORITY JOURNAL; PULSE PRESSURE;

EID: 0034964520     PISSN: 08957061     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0895-7061(01)02131-8     Document Type: Conference Paper

References (25)

1. The sixth report of the National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure
2. Prevalence of hypertension in the US adult population
3. Prevention of heart failure by antihypertensive drug treatment in older persons with isolated systolic hypertension
4. The epidemiological association between blood pressure and stroke: Implications for primary and secondary prevention
5. Blood pressure and high blood pressure. Aspects of risk
6. Blood pressure and mortality among men with prior myocardial infarction
7. Is pulse pressure useful in predicting risk for coronary heart disease? The Framingham Heart Study
8. Implications of the systolic hypertension in the elderly program
9. Evolution of hypertension from nonhypertensive blood pressure levels: Rates of progression in the Framingham Heart Study
10. Blood pressure as a cardiovascular risk factor. Prevention and treatment
11. A clinical trial of the effects of dietary patterns on blood pressure
12. The effects of nonpharmacologic interventions on blood pressure of persons with high normal levels
13. Alcohol use and blood pressure
14. Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: Principal results of the Hypertension Optimal Treatment (HOT) randomised trial
15. Systolic hypertension in Europe (Syst-Eur) trial phase 2: Objectives, protocol, and initial progress
16. Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. Final results of the Systolic Hypertension in the Elderly Program (SHEP)
17. Morbidity and mortality in the Swedish Trial in Old Patients with Hypertension (STOP-Hypertension)
18. Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38
19. Effect of blood pressure control on diabetic microvascular complications in patients with hypertension and type 2 diabetes
20. Geriatric hypertension
21. Medical Research Council trial of treatment of hypertension in older adults: Principal results
22. Effect of angiotensin-converting-enzyme inhibition compared with conventional therapy on cardiovascular morbidity and mortality in hypertension: The Captopril Prevention Project (CAPPP)
23. Randomised trial of old and new antihypertensive drugs in elderly patients: Cardiovascular mortality and morbidity in the Swedish Trial in Old Patients with Hypertension-2 study
24. Major cardiovascular events in hypertensive patients randomized to doxazosin vs chlorthalidone. The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)
25. A multicenter, community-based study of doxazosin in the treatment of concomitant hypertension and symptomatic benign prostatic hyperplasia: The Hypertension and BPH Intervention Trial (HABIT)